Lupin Pharmaceuticals Inc. is recalling 876 bottles of Desoximetasone Topical Spray, 0.25% (2.5 mg) because testing revealed high levels of impurities and product degradation that exceeded approved limits. Using a medication with excessive impurities or degraded ingredients can lead to reduced effectiveness or unintended reactions. This recall affects 100 mL prescription bottles distributed nationwide with expiration dates in May and June 2020. Consumers are advised to contact their healthcare provider or pharmacist for guidance on their treatment.
The medication failed stability specifications due to high out-of-specification results for impurities and degradation products. This chemical failure means the drug's potency and safety profile may be compromised, potentially resulting in skin irritation or a failure to treat the underlying condition.
Pharmacy refund and consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.